1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Cofactor Genomics Acquires Narus Biotechnologies

M&A Deal Summary

Cofactor Genomics Acquires Narus Biotechnologies

On February 5, 2016, Cofactor Genomics acquired life science company Narus Biotechnologies

Acquisition Highlights
  • This is Cofactor Genomics’ 1st transaction in the Life Science sector.
  • This is Cofactor Genomics’ 1st transaction in the United States.
  • This is Cofactor Genomics’ 1st transaction in California.

M&A Deal Summary
Date 2016-02-05
Target Narus Biotechnologies
Sector Life Science
Buyer(s) Cofactor Genomics
Deal Type Add-on Acquisition

Target

Narus Biotechnologies

San Francisco, California, United States
Narus Biotechnologies, Inc. is an early-stage molecular diagnostics company focused on helping physicians treat neurological diseases.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Cofactor Genomics

St. Louis, Missouri, United States
Category Company
Sector Life Science
DESCRIPTION

Cofactor Genomics, Inc. is a biotechnology company develops a platform based on RNA that enables early detection and diagnosis of a disease.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2016 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal